James Brady
Vermögen: 929 615 $ am 31.08.2026
Vermögen: 929 615 $ am 31.08.2026
James P.
Brady is currently Chief Human Resources Officer at Ardelyx, Inc. since 2025.
Formerly, Mr. Brady was Chief Human Resources Officer at Spero Therapeutics, Inc., Vice President-Human Resources at Intarcia Therapeutics, Inc. from 2015 to 2020, and Chief Human Resources Officer at uniQure NV from 2020 to 2021.
Education includes graduate studies at Harvard University and undergraduate studies at Marietta College.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ARDELYX, INC. 0,1 % | 21.08.2026 | 245.930 ( 0,1 % ) | 929 615 $ | 31.08.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ARDELYX, INC. | Personalreferent | 02.06.2025 |
| Unternehmen | Position | Ende |
|---|---|---|
| UNIQURE N.V. | Personalreferent | 01.09.2021 |
Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops innovative therapies utilizing the Medici drug delivery system | Personalreferent | 01.08.2020 |
| SPERO THERAPEUTICS, INC. | Personalreferent | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Marietta College
Marietta College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops innovative therapies utilizing the Medici drug delivery system | Health Technology |
Ardelyx, Inc.
Ardelyx, Inc. Pharmaceuticals: MajorHealth Technology Discovers and Develops therapeutic therapeutic drugs that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases | Health Technology |
uniQure NV
uniQure NV BiotechnologyHealth Technology Engages in the discovery, development and commercialization of gene therapies products | Health Technology |
Spero Therapeutics, Inc.
Spero Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of bacterial infections | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen